Rel Life Sciences lines up Rs 2,500 crore investment
MUMBAI: Mukesh Ambani-owned Reliance Life Scienceshas earmarked Rs 2,500 crore over the next two years for developing innovative gene therapies and vaccines, as well as capacity expansion. In one of its largest investments since its…